Illness	Number of cases
Malignant neoplasm of rectum (C20)	105
Malignant neoplasm of bronchus and lung (C34.1)	76
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	70
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	54
Malignant neoplasm of colon - Malignant neoplasm of sigmoid colon (C18.7)	52
Malignant neoplasm of colon - Malignant neoplasm of ascending colon (C18.2)	42
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	41
Non-follicular lymphoma (C83.3)	39
Malignant neoplasm of breast (C50.8)	37
Malignant neoplasm of bronchus and lung (C34.3)	31

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	767
Computed tomography of the chest with contrast medium (3-222)	574
Computed tomography of the abdomen with contrast medium (3-225)	543
(9-984.b)	503
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	277
(9-984.7)	273
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	255
(9-984.8)	232
Computed tomography (CT) of the chest without contrast medium (3-202)	219
Computed tomography (CT) of the abdomen without contrast medium (3-207)	183

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0105

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
79	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
60	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
60	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)